{"id":877215,"date":"2026-03-18T04:48:09","date_gmt":"2026-03-18T04:48:09","guid":{"rendered":"https:\/\/www.europesays.com\/de\/877215\/"},"modified":"2026-03-18T04:48:09","modified_gmt":"2026-03-18T04:48:09","slug":"delveinsight-business-research-llp-united-kingdom-united-states-of-america","status":"publish","type":"post","link":"https:\/\/www.europesays.com\/de\/877215\/","title":{"rendered":"DelveInsight Business Research, LLP United Kingdom United States of America"},"content":{"rendered":"


\n\t
\n\t\tGlobal<\/a>, Orphan<\/a>\t\t
\n\t\t18.03.2026 – 03:09:08 | prnewswire.co.uk
\n\t <\/p>\n

DelveInsight Business Research, LLP United Kingdom United States of America<\/p>\n


\n
\n\t
\n
\n\t <\/p>\n

+14699457679\u00a0<\/p>\n

Logo: https:\/\/mma.prnewswire.com\/media\/1082265\/3528414\/DelveInsight_Logo.jpg<\/a><\/p>\n

\u00a0<\/p>\n

\"Cision\" View original content:https:\/\/www.prnewswire.co.uk\/news-releases\/global-orphan-drugs-market-is-anticipated-to-cross-usd-350-billion-by-2032–delveinsight-302702148.html<\/a><\/p>\n

\t
\n
\n
\n\t\t\t\t
\n\t\t\t\t\t\t\t\t <\/p>\n

\t\t Hol dir jetzt den Wissensvorsprung der Aktien-Profis.<\/b>
\n\t\t\t\t\t\"<\/p>\n

Seit 2005 liefert der B\u00f6rsenbrief trading-notes<\/b> verl\u00e4ssliche Aktien-Empfehlungen – Dreimal die Woche, direkt ins Postfach. 100% kostenlos. 100% Expertenwissen.<\/b> Trage einfach deine E-Mail Adresse ein und verpasse ab heute keine Top-Chance mehr. Jetzt abonnieren.
F\u00fcr. Immer. Kostenlos.<\/strong><\/a> <\/a><\/strong><\/p>\n

\t
\n\t <\/p>\n


\n\t
\n\t\t\t\t\t\t\tboerse | 68768753 | \t\t\t\t \n\t<\/p>\n


\n <\/p>\n","protected":false},"excerpt":{"rendered":" Global, Orphan 18.03.2026 – 03:09:08 | prnewswire.co.uk DelveInsight Business Research, LLP United Kingdom United…\n","protected":false},"author":2,"featured_media":9969,"comment_status":"","ping_status":"","sticky":false,"template":"","format":"standard","meta":{"footnotes":"","_share_on_mastodon":"0"},"categories":[3976],"tags":[331,332,193641,91800,193642,193643,42476,12866,13,18906,14,15,193640,12,3992,3993,3994,193399,3995,3996,3997],"class_list":["post-877215","post","type-post","status-publish","format-standard","has-post-thumbnail","category-vereinigtes-koenigreich","tag-aktuelle-nachrichten","tag-aktuelle-news","tag-anticipated","tag-billion","tag-cross","tag-delveinsight","tag-drugs","tag-global","tag-headlines","tag-market","tag-nachrichten","tag-news","tag-orphan","tag-schlagzeilen","tag-uk","tag-united-kingdom","tag-united-kingdom-of-great-britain-and-northern-ireland","tag-usd","tag-vereinigtes-koenigreich","tag-vereinigtes-koenigreich-grossbritannien-und-nordirland","tag-vereinigtes-koenigreich-von-grossbritannien-und-nordirland"],"share_on_mastodon":{"url":"https:\/\/pubeurope.com\/@de\/116248373176963722","error":""},"_links":{"self":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts\/877215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/comments?post=877215"}],"version-history":[{"count":0,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/posts\/877215\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/media\/9969"}],"wp:attachment":[{"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/media?parent=877215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/categories?post=877215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.europesays.com\/de\/wp-json\/wp\/v2\/tags?post=877215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}